세계 DNA 시퀀싱 시장 규모는 2024년 148억 달러에서 예측 기간 동안 CAGR 18.6%로 추이하고 2029년 말에는 348억 달러에 달할 것으로 예측되고 있습니다.
북미 시장은 2024년 70억 달러에서 예측 기간 동안 CAGR 18.8%로 추이하고, 2029년 말에는 164억 달러에 달할 것으로 예측되고 있습니다. 유럽 시장은 2024년 38억 달러에서 CAGR는 18.5%로 성장을 지속하여 2029년 말에는 88억 달러에 달할 것으로 예측됩니다.
이 보고서는 세계 DNA 시퀀싱 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 구분 및 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 주요 요약
제2장 시장 개요
- DNA의 중요성
- 유전적 변이와 분석
- 시퀀싱의 역사
- NGS(2세대 시퀀싱)
- TGS(롱 리드 시퀀싱)
- 연구와 응용
- R&D 용도
- 응용 분야
- 소비자에게 직접 판매
- 바이오의약품
- 농업
- 법의학
- 마이크로바이옴
- 합성 생물학
제3장 시장 역학
- 시장 역학 스냅샷
- 시장 성장 촉진요인
- 시퀀싱 기술의 기술적 진보
- 임상 진단에서 DNA 시퀀싱의 응용 증가
- 시장 성장 억제요인
- DNA 서열 분석의 고비용
- 데이터의 해석과 관리의 과제
- 시장 기회
- 정밀의료의 확대
- NIPT의 성장
제4장 신기술
- 롱 리드 시퀀싱 기술
- SMRT 시퀀싱
- 나노포어 시퀀싱
- 공간 유전체학와 전사체학
- 단일 세포 DNA 시퀀싱
- 초저 입력 시퀀싱
- CRISPR-Cas9와 유전자 편집과 시퀀싱 기술의 통합
- DNA 시퀀싱에 있어서의 AI와 머신러닝
제5장 시장 세분화 분석
- 세분화의 내역
- 세계의 DNA 시퀀싱 시장의 분석 : 제품?서비스별
- 기구 및 소모품
- 서비스
- 세계의 DNA 시퀀싱 시장의 분석 : 기술별
- 차세대 시퀀싱
- TGS
- 산가 시퀀싱
- 파이로 시퀀싱
- 세계의 DNA 시퀀싱 시장의 분석 : 용도별
- 바이오의약품
- 미생물학
- 농업
- 기타(합성 생물학, 집단 유전체학, 소비자 유전체학)
- 세계 DNA 시퀀싱 시장 분석 : 최종 사용자별
- 시장 규모와 예측
- 학술연구기관
- 병원 및 진료소
- 제약·바이오테크놀러지 기업
- 임상 연구
- 기타(농업기관, 법의학연구소)
- 세계 DNA 시퀀싱 시장 분석 : 질병 카테고리별
- 시장 규모와 예측
- 암
- 생식에 관한 건강
- 멘델 유전병
- 기타(심장병학, 대사/면역학, 신경학, 이식, 임상)
- 지리적 내역
- 세계 DNA 시퀀싱 시장 분석 : 지역별
- 시장 규모와 예측
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 구도
제7장 ESG 관점
- 시장에서 ESG 성능
- DNA 시퀀싱 업계에서 ESG 실습
- 환경 성능
- 사회적 퍼포먼스
- 거버넌스 퍼포먼스
- DNA 시퀀싱 업계에서 ESG 위험 평가
- BCC에 의한 총론
제8장 부록
- 조사 방법
- 출처
- 약어
- 기업 프로파일
- AGILENT TECHNOLOGIES INC.
- BGI
- F. HOFFMANN-LA ROCHE LTD.
- GUARDANT HEALTH
- ILLUMINA INC.
- MYRIAD GENETICS INC.
- OXFORD NANOPORE TECHNOLOGIES PLC.
- PACBIO
- QIAGEN
- THERMO FISHER SCIENTIFIC INC.
- Other Key Companies Offering DNA Sequencing Services
- 10X GENOMICS
- CROWN BIOSCIENCE
- EUROFINS GENOMICS
- GENEWIZ, FROM AZENTA LIFE SCIENCES
- INTEGRATED DNA TECHNOLOGIES, INC
- MACROGEN
- NOVOGENE CO., LTD.
- REVVITY
JHS
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
The North American DNA sequencing market is expected to grow from $7.0 billion in 2024 and is projected to reach $16.4 billion by the end of 2029, at a CAGR of 18.8% during the forecast period of 2024 to 2029.
The European DNA sequencing market is expected to grow from $3.8 billion in 2024 and is projected to reach $8.8 billion by the end of 2029, at a CAGR of 18.5% during the forecast period of 2024 to 2029.
Report Scope
The report highlights the current and future market potential of DNA sequencing and provides a detailed analysis of market drivers, restraints and opportunities. The report also gives market projections for 2029 and includes a competitive environment and product analysis. The report provides market estimates and forecasts for DNA sequencing based on technology, product & service, end user, application, disease category, and region. By technology, the market is segmented into next-generation sequencing (NGS), third-generation sequencing (TGS), pyrosequencing, and Sanger sequencing. By product and service, the market is categorized into instruments and consumables or services. By end user, the market is segmented into academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, contract research organizations, and others. By application, the market is categorized as biopharma, microbiology, agriculture, or others. By disease category, the market is segmented into cancer, reproductive health, Mendelian disorders, and others. The report includes the company profiles of the key players, with detailed information about their business segments, financials, product portfolios, and recent developments.
By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; Asia-Pacific includes China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years and for 2023 as the base year, with forecasts through 2029.
Report Includes
- 70 data tables and 59 additional tables
- An overview of the global market for DNA sequencing technologies and their applications in research, applied and clinical segments
- Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- A market forecast for the DNA sequencing industry, and a corresponding market share analysis by products and services, end-use segment, application, disease category and region
- A look at the key market dynamics for DNA sequencing, and the regulatory scenario
- Discussion of market opportunities for DNA sequencing, industry structure, applications and business considerations of sequencing technologies, along with the ongoing changes in the structure of the MedTech industry
- Review of the leading next-generation sequencing (NGS) technologies, emerging applications, and the DNA sequencing-based diagnostics and research initiatives affecting the market
- Analysis of patents related to novel sequencing technologies, as well as clinical trials
- A discussion of ESG challenges and ESG practices in the industry
- Insights into the major acquisitions and strategic alliances, competitive benchmarking of sequencing industry participants and their growth strategies
- Market share analysis of the leading companies, as well as company profiles, including Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences (PacBio), and Oxford Nanopore Technologies Ltd.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Insights
Chapter 2 Market Overview
- Importance of DNA
- Genetic Variation and Analysis
- History of Sequencing
- NGS (Second-generation Sequencing)
- TGS (Long-read Sequencing)
- Research and Applied Applications
- R&D Applications
- Applied Applications
- Direct to Consumer
- Biopharma
- Agriculture
- Forensics
- Microbiome
- Synthetic Biology
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Technological Advances in Sequencing Techniques
- Rising Applications of DNA Sequencing in Clinical Diagnostics
- Market Restraints
- High Cost of DNA Sequencing
- Data Interpretation and Management Challenges
- Market Opportunities
- Expansion of Precision Medicine
- Growth in NIPT
Chapter 4 Emerging Technologies
- Long-read Sequencing Technologies
- SMRT Sequencing
- Nanopore Sequencing
- Spatial Genomics and Transcriptomics
- Single-cell DNA Sequencing
- Ultra-low Input Sequencing
- CRISPR-Cas9 and Genome-editing Integration with Sequencing Technologies
- AI and Machine Learning in DNA Sequencing
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Global DNA Sequencing Market Analysis by Product and Service
- Instruments and Consumables
- Services
- Global DNA Sequencing Market Analysis by Technology
- NGS
- TGS
- Sanger Sequencing
- Pyrosequencing
- Global DNA Sequencing Market Analysis by Application
- Biopharma
- Microbiology
- Agriculture
- Others (Synthetic Biology, Population Genomics, and Consumer Genomics)
- Global DNA Sequencing Market Analysis by End User
- Market Size and Forecast
- Academic and Research Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Clinical Research
- Others (Agricultural Institutions, Forensic Labs)
- Global DNA Sequencing Market Analysis by Disease Category
- Market Size and Forecast
- Cancer
- Reproductive Health
- Mendelian Disorders
- Others (Cardiology, Metabolic/Immune, Neurology, Transplant, Clinical)
- Geographic Breakdown
- Global DNA Sequencing Market Analysis by Region
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 6 Competitive Landscape
- Overview
- Partnerships
- Investments and Funding
- Patent Analysis
Chapter 7 ESG Perspective
- Introduction
- ESG Performance in the Market
- ESG Practices in the DNA Sequencing Industry
- Environmental Performance
- Social Performance
- Governance Performance
- ESG Risk Ratings in the DNA Sequencing Industry
- Concluding Remarks from BCC Research
Chapter 8 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BGI
- F. HOFFMANN-LA ROCHE LTD.
- GUARDANT HEALTH
- ILLUMINA INC.
- MYRIAD GENETICS INC.
- OXFORD NANOPORE TECHNOLOGIES PLC.
- PACBIO
- QIAGEN
- THERMO FISHER SCIENTIFIC INC.
- Other Key Companies Offering DNA Sequencing Services
- 10X GENOMICS
- CROWN BIOSCIENCE
- EUROFINS GENOMICS
- GENEWIZ, FROM AZENTA LIFE SCIENCES
- INTEGRATED DNA TECHNOLOGIES, INC
- MACROGEN
- NOVOGENE CO., LTD.
- REVVITY
